Demand for convenient care drives new healthcare partnerships

Partnerships—including joint ventures, non-exclusive arrangements and telehealth alliances—are becoming more common as a result of the “convenient care” revolution, according to NEJM Catalyst.

Authors Pushpa Raja, MD, of UCLA; and Ateev Mehrotra, MD, MPH, of Harvard, explained that the first types of these convenient care options are retail clinics, urgent care centers, telehealth kiosks and online video visits. With new technology, these options are able to offer patients extended hours, minimal wait times, and low out-of-pocket costs for low-acuity conditions.

The demand for these convenient care options is highest among urban, higher-income, younger and healthier demographics. While larger healthcare systems have an interest to break into this market, they often lack the infrastructure to do so solo, leading to partnerships with those who can provide simple, low-acuity care. This is especially true if the healthcare system attracts the demographic of patient that demands this new type of care delivery.

Partnerships between health systems and providers of convenient care come in many shapes and sizes, wrote Raja and Mehrotra, and include:

  • Non-exclusive agreements: Institutions outside the healthcare sector, such as CVS, have been popular choices for convenient-care partnerships due to their built-in customer base and relatively low financial risk for health systems.
  • Joint ventures: Under these arrangements, every partner has a stake, appealing to healthcare providers who are willing to make a bigger capital investment in exchange for more ownership and equal representation on boards of directors.
  • Leased-space arrangements: Health systems operate convenient-care clinics themselves, but within a retail space. “The drawback of such an arrangement is that, again, health systems often lack the infrastructure to operate such a clinic; for example, more than half of hospital-operated clinics within Walmart locations have since closed,” wrote Raja and Mehrotra.
  • Telemedicine partnerships: These can include healthcare providers paying a fee for services and technology in exchange for branding and referrals

“Convenient-care partnerships won’t work for every health system,” concluded Raja and Mehrotra. “Those that value direct control of quality, reimbursement, and staff culture over lower operational costs may continue to create convenient-care options in-house or partner with outsiders only for technology infrastructure. Others may wait to assess how well existing partnerships work before joining the fray. But as convenience becomes a core value for many patients, health systems should at least become familiar with the partnership landscape and its growing options.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.